...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Sao Paulo Medical Journal >Psychoactive drug advertising: a comparison of technical information from three countries: Brazil, United States and United Kingdom
【24h】

Psychoactive drug advertising: a comparison of technical information from three countries: Brazil, United States and United Kingdom

机译：精神药物广告：巴西，美国和英国三个国家/地区的技术信息比较

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

CONTEXT AND OBJECTIVE: Studies carried out in the 1970s and 1980s showed that there were country-dependent disparities in the information given for the same drug in medical advertisements. National and international regulations have been published to do away with such disparities and to foster the rational use of drugs. The purpose of this study was to compare the information contained in psychoactive drug advertisements published in psychiatric journals in Brazil, the United States and the United Kingdom, before and subsequent to the publication of the United States Export Act, in 1986, the WHO criteria, in 1988, and the Brazilian Sanitary Surveillance Agency Resolution no. 102, in 2000. TYPE OF STUDY AND SETTING: Content analysis, at Centro Brasileiro de Informa??es sobre Drogas Psicotrópicas (Cebrid). METHODS: We gathered advertisements from Brazilian, American and British psychiatry periodicals published before and after each ruling. We analyzed a total of twenty-four Brazilian advertisements that were for the same psychoactive drugs as advertised in American and/or British publications from the same period. RESULTS: We observed that Brazilian advertisements omitted information on usage restrictions, such as contraindications, adverse reactions, interactions, warnings and precautions, and that such information was present in American and British advertisements. CONCLUSIONS: The data suggest that disparities in the information given for the same drug still persist. The information depends on the country in which each drug is marketed. The legislation is insufficient for eradicating such disparities.
机译：内容与目的：1970年代和1980年代进行的研究表明，医疗广告中针对同一药物的信息存在国家差异。已经发布了国家和国际法规来消除这种差异并促进合理使用毒品。这项研究的目的是比较1986年《美国出口法》公布前后，在巴西，美国和英国的精神病学杂志上刊登的精神药物广告中所包含的信息， 1988年颁布的巴西卫生监督局决议。 102，在2000年。研究和环境类型：内容分析，在巴西国家信息中心进行，德罗加斯·皮斯科塔皮卡斯（塞卜里德）。方法：我们收集了巴西，美国和英国精神病学期刊在每次裁决前后发布的广告。我们分析了总共二十四个巴西广告，这些广告与同一时期在美国和/或英国出版物中刊登的相同的精神药物有关。结果：我们观察到，巴西的广告省略了有关使用限制的信息，例如禁忌症，不良反应，相互作用，警告和注意事项，并且这些信息出现在美国和英国的广告中。结论：数据表明，相同药物的信息仍然存在差异。该信息取决于每种药物的销售国家。立法不足以消除这种差距。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号